✦ LIBER ✦

404 POSTER Pharmacodynamics (pd) of x1880, a novel spectrum selective kinase inhibitor (SSKI), administered orally to patients (pts) with advanced solid tumors (AST)

✍ Scribed by P. LoRusso; L. Appleman; A. Zhu; G. Shapiro; L. Fox; A. Wolanski; S. Hitchcock-Bryan; L. Malburg; J. Eder

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

383 POSTER A phase 1 study of XL281, a p

✍ G.K. Schwartz; S. Yazji; D.S. Mendelson; M.A. Dickson; S.H. Johnston; E.W. Wang; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

97 POSTER A phase I dose-escalation stud

✍ K. Papadopoulos; J. Rodon; A. Mita; P. O'Rourke; A. Patnaik; E. Rubin; A. Tolche 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

342 POSTER A phase I dose-escalation and

✍ B.I. Sikic; H.A. Wakelee; A.A. Adjei; J. Halsey; J.L. Lensing; J.D. Dugay; L.J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 68 KB

218 POSTER A phase I dose-escalation stu

✍ E. Calvo; G. Edelman; J. Baselga; E. Kwak; C. Scheffold; L. Nguyen; G.I. Shapiro 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

216 POSTER A phase I dose-escalation stu

✍ B. Markman; P.M. LoRusso; A. Patnaik; E. Heath; A.D. Laird; B. van Leeuwen; K.P. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB